Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/TauRx_Therapeutics> ?p ?o }
Showing triples 1 to 64 of
64
with 100 triples per page.
- TauRx_Therapeutics abstract "TauRx Therapeutics Ltd is a life sciences/pharmaceutical company incorporated in Singapore with primary research facilities and operations in Aberdeen, Scotland.The company was co-founded in 2002 by the late gynecologist, surgeon and venture capitalist K. M. Seng and Claude Wischik, Professor of Old Age Psychiatry at the University of Aberdeen, Scotland, who is currently the company's Executive Chairman.The company's protein aggregation inhibitors target the underlying pathology of dementia, with the aim of modifying or halting disease progression. Their lead compound, LMTX™, targets aggregation of tau and is believed to act on synuclein, TDP-43 and huntingtin protein. Its primary development in Alzheimer's disease is focused in its activity as a Tau Aggregation Inhibitor (TAI).In 1988, while at Cambridge University, Wischik and coworkers discovered that abnormal fibres of tau protein form inside nerve cells in patients with Alzheimer's disease, and that their aggregation into tau tangles correlates to the development of dementia. In 1997, Wischik and his team moved to the University of Aberdeen, where they continued their pioneering research into tau pathology and protein aggregation inhibition. In 2002, the company was formed as a spin-out of the University of Aberdeen.Rember - a first generation TAI - was used in Phase 2 clinical trials in Alzheimer's, with encouraging results announced by Wischik and colleagues in July 2008 at the Alzheimer's Association's International Conference on Alzheimer's Disease (ICAD 2008) in Chicago. The Phase 2 results were published in the Journal of Alzheimer's Disease in January 2015.In the latter part of 2012, the company announced that it had initiated Phase 3 clinical trials with LMTXTM for mild and moderate Alzheimer's disease and behavioral variant FTD (bvFTD). In January 2015, the company announced that all three Phase 3 clinical trials were fully recruited.".
- TauRx_Therapeutics foundationPlace Singapore.
- TauRx_Therapeutics foundingYear "2002".
- TauRx_Therapeutics industry List_of_life_sciences.
- TauRx_Therapeutics internationally "true".
- TauRx_Therapeutics keyPerson Chairman.
- TauRx_Therapeutics keyPerson Chief_executive_officer.
- TauRx_Therapeutics wikiPageExternalLink www.taurx.com.
- TauRx_Therapeutics wikiPageExternalLink www.taurx.com.
- TauRx_Therapeutics wikiPageID "18651382".
- TauRx_Therapeutics wikiPageLength "6200".
- TauRx_Therapeutics wikiPageOutDegree "24".
- TauRx_Therapeutics wikiPageRevisionID "679095560".
- TauRx_Therapeutics wikiPageWikiLink Aberdeen.
- TauRx_Therapeutics wikiPageWikiLink Alzheimers_disease.
- TauRx_Therapeutics wikiPageWikiLink Category:Companies_of_Singapore.
- TauRx_Therapeutics wikiPageWikiLink Category:Pharmaceutical_companies.
- TauRx_Therapeutics wikiPageWikiLink Chairman.
- TauRx_Therapeutics wikiPageWikiLink Chief_executive_officer.
- TauRx_Therapeutics wikiPageWikiLink Dementia.
- TauRx_Therapeutics wikiPageWikiLink Gynaecology.
- TauRx_Therapeutics wikiPageWikiLink List_of_life_sciences.
- TauRx_Therapeutics wikiPageWikiLink Methylene_blue.
- TauRx_Therapeutics wikiPageWikiLink Pharmaceutical_industry.
- TauRx_Therapeutics wikiPageWikiLink Scotland.
- TauRx_Therapeutics wikiPageWikiLink Singapore.
- TauRx_Therapeutics wikiPageWikiLink Surgeon.
- TauRx_Therapeutics wikiPageWikiLink Tau_protein.
- TauRx_Therapeutics wikiPageWikiLink University_of_Aberdeen.
- TauRx_Therapeutics wikiPageWikiLink University_of_Cambridge.
- TauRx_Therapeutics wikiPageWikiLink Venture_capital.
- TauRx_Therapeutics foundation Singapore.
- TauRx_Therapeutics founder "Dr K. M. Seng".
- TauRx_Therapeutics founder "Professor Claude Wischik".
- TauRx_Therapeutics homepage www.taurx.com.
- TauRx_Therapeutics industry "Pharmaceuticals, Life Sciences".
- TauRx_Therapeutics intl "yes".
- TauRx_Therapeutics keyPeople "Dr Shay Way Seng, (Managing Director)".
- TauRx_Therapeutics keyPeople "Professor Claude Wischik, (Executive Chairman)".
- TauRx_Therapeutics locations "Singapore and Aberdeen, Scotland".
- TauRx_Therapeutics name "TauRx Therapeutics".
- TauRx_Therapeutics wikiPageUsesTemplate Template:Clear.
- TauRx_Therapeutics wikiPageUsesTemplate Template:Infobox_company.
- TauRx_Therapeutics subject Category:Companies_of_Singapore.
- TauRx_Therapeutics subject Category:Pharmaceutical_companies.
- TauRx_Therapeutics hypernym Sciences.
- TauRx_Therapeutics type Agent.
- TauRx_Therapeutics type Company.
- TauRx_Therapeutics type Organisation.
- TauRx_Therapeutics type Company.
- TauRx_Therapeutics type Organization.
- TauRx_Therapeutics type Agent.
- TauRx_Therapeutics type SocialPerson.
- TauRx_Therapeutics type Thing.
- TauRx_Therapeutics type Q43229.
- TauRx_Therapeutics comment "TauRx Therapeutics Ltd is a life sciences/pharmaceutical company incorporated in Singapore with primary research facilities and operations in Aberdeen, Scotland.The company was co-founded in 2002 by the late gynecologist, surgeon and venture capitalist K. M.".
- TauRx_Therapeutics label "TauRx Therapeutics".
- TauRx_Therapeutics sameAs Q7688600.
- TauRx_Therapeutics sameAs m.04gnrgm.
- TauRx_Therapeutics sameAs Q7688600.
- TauRx_Therapeutics wasDerivedFrom TauRx_Therapeutics?oldid=679095560.
- TauRx_Therapeutics homepage www.taurx.com.
- TauRx_Therapeutics isPrimaryTopicOf TauRx_Therapeutics.
- TauRx_Therapeutics name "TauRx Therapeutics".